These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 35543075)

  • 21. A Dual-Targeting Functionalized Graphene Film for Rapid and Highly Sensitive Fluorescence Imaging Detection of Hepatocellular Carcinoma Circulating Tumor Cells.
    Wu C; Li P; Fan N; Han J; Zhang W; Zhang W; Tang B
    ACS Appl Mater Interfaces; 2019 Dec; 11(48):44999-45006. PubMed ID: 31714050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients.
    Chen J; Cao SW; Cai Z; Zheng L; Wang Q
    Cancer Biomark; 2017 Dec; 20(4):487-498. PubMed ID: 28869439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A New Cell Block Method for Multiple Immunohistochemical Analysis of Circulating Tumor Cells in Patients with Liver Cancer.
    Nam SJ; Yeo HY; Chang HJ; Kim BH; Hong EK; Park JW
    Cancer Res Treat; 2016 Oct; 48(4):1229-1242. PubMed ID: 27034142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of EpCAM mRNA-positive circulating tumor cells in hepatocellular carcinoma by an optimized negative enrichment and qRT-PCR-based platform.
    Guo W; Yang XR; Sun YF; Shen MN; Ma XL; Wu J; Zhang CY; Zhou Y; Xu Y; Hu B; Zhang X; Zhou J; Fan J
    Clin Cancer Res; 2014 Sep; 20(18):4794-805. PubMed ID: 25009297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.
    Schulze K; Gasch C; Staufer K; Nashan B; Lohse AW; Pantel K; Riethdorf S; Wege H
    Int J Cancer; 2013 Nov; 133(9):2165-71. PubMed ID: 23616258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.
    Zhou Y; Wang B; Wu J; Zhang C; Zhou Y; Yang X; Zhou J; Guo W; Fan J
    BMC Cancer; 2016 Jul; 16():506. PubMed ID: 27439521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liquid Biopsy in Hepatocellular Carcinoma: The Significance of Circulating Tumor Cells in Diagnosis, Prognosis, and Treatment Monitoring.
    Shaik MR; Sagar PR; Shaik NA; Randhawa N
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating tumor DNA/circulating tumor cells and the applicability in different causes induced hepatocellular carcinoma.
    Li X; Wang H; Li T; Wang L; Wu X; Liu J; Xu Y; Wei W
    Curr Probl Cancer; 2020 Apr; 44(2):100516. PubMed ID: 31836136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical value of circulating tumor cells for the diagnosis and prognosis of hepatocellular carcinoma (HCC): A systematic review and meta-analysis.
    Cui K; Ou Y; Shen Y; Li S; Sun Z
    Medicine (Baltimore); 2020 Oct; 99(40):e22242. PubMed ID: 33019399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Labyrinth Microfluidic Device Detects Circulating Tumor Cells Expressing Cancer Stem Cell Marker and Circulating Tumor Microemboli in Hepatocellular Carcinoma.
    Wan S; Kim TH; Smith KJ; Delaney R; Park GS; Guo H; Lin E; Plegue T; Kuo N; Steffes J; Leu C; Simeone DM; Razimulava N; Parikh ND; Nagrath S; Welling TH
    Sci Rep; 2019 Dec; 9(1):18575. PubMed ID: 31819089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease.
    Li YM; Xu SC; Li J; Han KQ; Pi HF; Zheng L; Zuo GH; Huang XB; Li HY; Zhao HZ; Yu ZP; Zhou Z; Liang P
    Cell Death Dis; 2013 Oct; 4(10):e831. PubMed ID: 24091674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
    Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early dynamic changes in circulating tumor cells and prognostic relevance following interventional radiological treatments in patients with hepatocellular carcinoma.
    Vogl TJ; Riegelbauer LJ; Oppermann E; Kostantin M; Ackermann H; Trzmiel A; Stein S; Eichler K; Zharov VP; Roy D; Schnitzbauer AA; Strücker B; Pascher A; Bechstein WO; Juratli MA
    PLoS One; 2021; 16(2):e0246527. PubMed ID: 33577574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating tumor cells as a prognostic biomarker in patients with hepatocellular carcinoma.
    Prasoppokakorn T; Buntho A; Ingrungruanglert P; Tiyarattanachai T; Jaihan T; Kulkraisri K; Ariyaskul D; Phathong C; Israsena N; Rerknimitr R; Treeprasertsuk S; Chaiteerakij R
    Sci Rep; 2022 Nov; 12(1):18686. PubMed ID: 36333384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
    Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
    BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?
    Ogle LF; Orr JG; Willoughby CE; Hutton C; McPherson S; Plummer R; Boddy AV; Curtin NJ; Jamieson D; Reeves HL
    J Hepatol; 2016 Aug; 65(2):305-13. PubMed ID: 27132171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of circulating tumor cells in patients with hepatocellular carcinoma recurrence following liver transplantation.
    Wang S; Zheng Y; Liu J; Huo F; Zhou J
    J Investig Med; 2018 Jun; 66(5):1-6. PubMed ID: 29632031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A clinically feasible circulating tumor cell sorting system for monitoring the progression of advanced hepatocellular carcinoma.
    Huang XY; Li F; Li TT; Zhang JT; Shi XJ; Huang XY; Zhou J; Tang ZY; Huang ZL
    J Nanobiotechnology; 2023 Jan; 21(1):25. PubMed ID: 36681851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses.
    Yin LC; Luo ZC; Gao YX; Li Y; Peng Q; Gao Y
    Biomed Res Int; 2018; 2018():3789613. PubMed ID: 30046595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma.
    Chen J; Luo Y; Xi X; Li H; Li S; Zheng L; Yang D; Cai Z
    Front Oncol; 2022; 12():931140. PubMed ID: 36465354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.